홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Magnesium Hydroxide → CID 64738

HRID 859095
인쇄

반응식

HRID 859095 반응식
[OH-].[Mg+2:2].[OH-].[C:4]([O-:13])(=[O:12])[C:5]1[C:6](=[CH:8][CH:9]=[CH:10][CH:11]=1)[OH:7].[Na+]>O>[C:4]([O-:13])(=[O:12])[C:5]1[C:6](=[CH:8][CH:9]=[CH:10][CH:11]=1)[OH:7].[Mg+2:2].[C:4]([O-:13])(=[O:12])[C:5]1[C:6](=[CH:8][CH:9]=[CH:10][CH:11]=1)[OH:7]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 73981Magnesium HydroxideHCID 16760658Sodium Salicylate

생성물 1

HCID 64738CID 64738

시약·촉매·용매 1

HCID 962Water용매

실험 절차

Magnesium hydroxide (0.0116 g; 0.0002 mol) is dissolved in 100 ml of water by gradual stirring. 0.03 g (0.0002 mols) of sodium salicylate is added to the solution to yield a magnesium salicylate molar ratio of 1:1. The resulting solution added to a 300 ml solution containing 0.225 g of membrane translocating peptide. The resulting solution is stirred at 4° Celsius for 12 hours and lyophilized to a volume of 200 ml. The solution is left to precipitate an inventive complex. The complex is filtered, washed with ether and purified commensurate with pharmaceutical purity requirements.

출처 및 근거

ORD 기록
ord-b473986c9968452e9e24d2584d770049
출처 데이터셋
uspto-grants-2006_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07151084B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트